HCPCS code C1830: Powered bone marrow biopsy needle guide

Key takeaways

HCPCS code C1830 reports a powered bone marrow biopsy needle, and only a hospital outpatient department can bill it.

The code describes the device, so the physician still reports the biopsy itself with a separate CPT code.

OPPS usually packages device payment into the APC for the procedure, so check the status indicator in Addendum B.

A C1830 charge survives review only when the operative note names a powered device in words a coder can verify.

Practice management software like Pabau keeps device and treatment detail inside the clinical record, so documentation is ready when a payer asks.

HCPCS code C1830 reports a powered bone marrow biopsy needle on a hospital outpatient claim. It describes the device, not the procedure. The physician bills the biopsy separately, under a CPT code, on a different claim form.

That split causes most of the friction. One team documents the needle, another codes it, and Medicare often folds the device payment into the procedure. If the operative note never says “powered,” the charge has nothing behind it on audit.

What HCPCS code C1830 covers

C1830 describes a powered bone marrow biopsy needle, a motorized device that drills through cortical bone to collect a marrow core. It sits in the HCPCS Level II C-code series. The Centers for Medicare and Medicaid Services (CMS) maintains that series for devices and items furnished in Medicare hospital outpatient departments.

C-codes are facility codes. A hospital outpatient department (HOPD) reports C1830 on the UB-04 institutional claim to identify the device it used. The attending physician reports the biopsy on a CMS-1500 claim with a CPT code. Two claims, two code sets, one encounter.

Why powered and manual needles code differently

The device decides the code. A powered needle uses a motor to rotate or oscillate the trocar through the cortex. A manual needle relies on the operator pushing and twisting by hand. C1830 applies to the first one only.

That distinction feels obvious in the procedure room. It stops being obvious three weeks later. A coder reads “bone marrow biopsy performed with needle and trocar” and has to decide whether the charge is supportable. It isn’t. Without the word “powered,” or a device name that traces to a powered system, the charge comes off.

Clinicians order the bone marrow test itself for a familiar set of hematologic reasons:

• Workup for suspected leukemia, lymphoma, or myeloma
• Staging of a confirmed hematologic cancer
• Evaluation of unexplained anemia, thrombocytopenia, or pancytopenia
• Treatment monitoring in myeloproliferative disorders
• Aplastic anemia diagnosis and follow-up

Volume is what turns a small mapping error into a large one. A hematology-heavy department runs this pathway daily, so one bad chargemaster line repeats hundreds of times before anyone spots it. Confirm that the powered device maps to C1830, and that the manual device maps nowhere near it.

How OPPS pays for C1830

Medicare pays for hospital outpatient services through the Outpatient Prospective Payment System, or OPPS. It groups services into Ambulatory Payment Classifications (APCs). Each APC carries a national payment rate, and a wage index then adjusts the labor share for local costs.

Devices behave differently from procedures inside that system. Instead of earning a line-item payment, most device codes get folded into the APC for the procedure they supported. So the honest answer to “what does C1830 pay?” is usually “nothing on its own.” The money arrives inside the biopsy’s APC.

CMS republishes those numbers every year, so a rate you looked up last January is already stale. Check these five fields in the current OPPS Addendum B:

What the status indicator tells you

The status indicator is the one field that answers whether Medicare pays C1830 separately. Two values matter for devices.

Status indicator N marks items and services packaged into the APC rate. Payment goes to the primary procedure, and the device line pays zero. Status indicator H marks a pass-through device category, which earns a separate payment on top of the APC rate.

Look the indicator up rather than assuming it. CMS moves codes between those buckets, and a change resets what your department can expect to collect.

How pass-through payment works

Pass-through status is temporary by design. CMS grants it to new device categories that meet a cost threshold. It then runs for at least two years and no more than three. When the window closes, the device drops back into standard APC packaging.

Budget for that cliff. A service line built on pass-through revenue will feel the change the January it expires. Nothing about the coding itself will have changed.

How to get a C1830 claim right the first time

Denials on device C-codes trace back to three things. The setting is wrong, the note never names the device, or the payer rejects the diagnosis. Device codes are a small piece of the revenue cycle, but they fail in predictable ways. Work through them in that order.

Who submits the code

Hospital outpatient departments submit C1830, and nobody else does. Physician group practices and freestanding ambulatory surgery centers outside OPPS jurisdiction don’t report C-codes at all. The attending physician’s CPT code goes on a separate CMS-1500 claim.

Office-based settings collect marrow too. Regenerative medicine practices aspirate marrow for concentrate, and they bill under the physician fee schedule. No C-code appears anywhere on that claim.

What the record has to show

Medicare Administrative Contractors (MACs) ask for the same five things every time. Missing one of them is the usual reason a C1830 charge doesn’t survive review.

• Operative or procedure note: states plainly that a powered bone marrow biopsy needle was used
• Device invoice or supply log: identifies the specific item and ties it to the encounter
• ICD-10-CM diagnosis codes: support medical necessity for marrow sampling
• Chargemaster entry: maps to C1830, with units matching the number of devices used
• Date alignment: the procedure date on the UB-04 matches the date in the note

Structured medical documentation keeps those five pieces in one place instead of three. A note that says only “biopsy needle” won’t support C1830 when a MAC requests records, whatever the invoice shows. Chapter 4 of the Medicare Claims Processing Manual is the operational reference for OPPS device reporting.

Better still, fix it at the source. Digital forms with required fields make the operator pick the device from a list before signing. The note then carries the word the coder needs, without anyone chasing it later.

How to count units

Bill one unit per powered needle used during the encounter. Two biopsy sites accessed with two separate powered needles support two units, as long as the note describes both.

Modifiers rarely apply here. C1830 is a device code, and most of the modifier logic that governs CPT reporting passes it by. Check your MAC’s local coverage determination (LCD) anyway, because jurisdictions differ.

Capturing units at the point of care beats rebuilding them from the chart a week later. That’s where EHR integration earns its keep.

Before you submit: a quick check

Six questions, asked before the claim leaves the building, catch nearly everything:

• Does the operative note name a powered device in verifiable words?
• Does the chargemaster line map to C1830 and to no manual-needle item?
• Do the units match the number of powered needles described?
• Does the claim carry a diagnosis this payer accepts for marrow sampling?
• Does the procedure date on the UB-04 match the date in the note?
• Is the device invoice or supply log filed against the encounter?

The codes that ride along with C1830

C1830 never travels alone. The facility claim carries the device code, the professional claim carries the CPT procedure code, and ICD-10-CM diagnoses support both. Here’s what usually appears alongside it.

Those descriptors changed in 2018. CPT used to read “aspiration only” and “biopsy, needle or trocar,” and plenty of chargemaster notes still quote the retired wording. If your crosswalk says “aspiration only,” it’s out of date.

Other device C-codes follow the same facility-only logic. C1827 and C1885 go on the same claim form, filed by the same team, under the same reporting rules.

To confirm a descriptor before you code, the AAPC code lookup shows C1830’s current wording and crosswalk references. The CMS annual HCPCS Level II file governs where the two disagree.

Diagnoses that support medical necessity

Every C1830 claim needs at least one ICD-10-CM code explaining why the marrow was sampled. These are the ones that show up most often.

Pick the most specific code the documentation supports. Unspecified codes are acceptable while the specific diagnosis is still unconfirmed, and not after. Pair C1830 with the diagnosis that drove the biopsy, never a lone symptom code.

Where commercial payers part ways with Medicare

C1830 is a Medicare construct. CMS built the C-code series for OPPS reporting, so coverage outside traditional Medicare isn’t guaranteed. The four payer types tend to behave like this:

• Medicare fee-for-service: C1830 is reportable when a powered device is used in an HOPD encounter, with payment set by APC assignment
• Medicare Advantage: plans cover Medicare-covered services, but billing rules and prior authorization vary by plan
• Commercial payers: many follow CMS guidance, though some use proprietary requirements or exclude C-codes entirely
• Medicaid: treatment varies by state, from CMS methodology to a flat device rate to no coverage at all

When a payer refuses C-codes outright, facilities usually report the device inside the overall facility charge instead. Get that instruction from the payer in writing and file it with the account.

Written guidance is what defends the approach on audit, and a routine chart audit finds the accounts where nobody wrote it down.

None of this is unique to bone marrow. Any claim carrying a billable supply runs the same gauntlet. IV therapy practices document drug and waste detail for exactly the same reason.

What C1830’s history tells you to check each year

CMS added C1830 to the HCPCS Level II code set effective October 1, 2011. It has been active ever since. That longevity is exactly why the code needs an annual review rather than a one-time setup.

The descriptor is stable. The payment treatment isn’t. CMS sets APC assignment, status indicator, and pass-through eligibility in the OPPS Final Rule each November. They take effect the following January.

You’ll also see C1830 listed in later CMS transmittals, inside routine device-code reference appendices. A transmittal number doesn’t establish when the code started or what it originally said. Treat those references as housekeeping, not history.

How Pabau keeps device detail in the clinical record

C1830 lives or dies on one line in the procedure note. Plenty of teams still write that note as free text. The word “powered” appears when the operator remembers it, and vanishes when they don’t. Nobody finds out until a payer asks.

Practice management software like Pabau moves that detail out of free text. Digital forms carry required fields, so the operator selects the device before the note can be signed. Stock tracking logs the specific item against the patient record at the same moment.

Checkout then builds an itemized invoice from what was actually used, so the charge and the clinical note agree from the start. Your coder gets a record that already answers the question they were going to ask.

One honest caveat: Pabau is built for private practices rather than hospital chargemasters. Treat it as the documentation layer feeding your billing, not as a replacement for your facility’s claim system.

Keep device detail inside the clinical record

Pabau's digital forms and stock tracking record the device used at the point of care. Your treatment note and your charge then agree before anyone bills.

Book a demo

Conclusion

The C1830 decision gets made in the procedure room, not in the billing office. If the note names a powered device, everything after that is bookkeeping. If it doesn’t, no amount of chargemaster tuning will rescue the charge.

So build the January habit. Pull Addendum B, check the status indicator, confirm pass-through status, and reconcile the chargemaster mapping. That’s an afternoon of work, and it holds for a year.

The documentation half is worth fixing at the source instead. Book a demo to see how Pabau captures device and treatment detail at the point of care.

Continue your research

Billing another OPPS device code? HCPCS code C1827 covers the neurostimulator generator code and the same facility-only reporting rules.

Coding a catheter on the same claim form? HCPCS code C1885 walks through the transluminal angioplasty laser catheter code.

Need the clinical picture behind the code? Bone marrow test explains what the sample shows and why clinicians order one.

Reporting other HCPCS codes in outpatient care? HCPCS code G0281 covers electrical stimulation for chronic wounds and its coverage limits.

Preparing for a records request? Medical chart audit shows how to review your documentation before a payer does.

Frequently asked questions